{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": 3.2258132, "regularMarketPrice": 0.032, "exchange": "FRA", "shortName": "REDWOOD PHARMA AB", "longName": "Redwood Pharma AB", "messageBoardId": "finmb_326373774", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683875702, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "sharesOutstanding": 105451000, "bookValue": 0.446, "fiftyDayAverage": 0.02368, "fiftyDayAverageChange": 0.008320002, "fiftyDayAverageChangePercent": 0.35135144, "twoHundredDayAverage": 0.06292, "twoHundredDayAverageChange": -0.030919995, "twoHundredDayAverageChangePercent": -0.49141762, "marketCap": 3374432, "priceToBook": 0.07174888, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1620280800000, "priceHint": 4, "regularMarketChange": 0.001000002, "regularMarketDayHigh": 0.032, "regularMarketDayRange": "0.032 - 0.032", "regularMarketDayLow": 0.032, "regularMarketVolume": 10000, "regularMarketPreviousClose": 0.031, "bid": 0.033, "ask": 0.038, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.032, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.020000001, "fiftyTwoWeekLowChangePercent": 1.6666667, "fiftyTwoWeekRange": "0.012 - 0.174", "fiftyTwoWeekHighChange": -0.14199999, "fiftyTwoWeekHighChangePercent": -0.8160919, "fiftyTwoWeekLow": 0.012, "fiftyTwoWeekHigh": 0.174, "symbol": "9JV.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Ringvagen 100E", "address2": "9th Floor", "city": "Stockholm", "zip": "118 60", "country": "Sweden", "website": "https://www.redwoodpharma.se", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women. It uses IntelliGel, a supramolecular smart drug delivery system for development of topical formulation for ophthalmic uses, as well as for administration to the front of the eye. Redwood Pharma AB was incorporated in 2012 and is headquartered in Stockholm, Sweden.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin  Vidaeus M.B.A., MBA", "age": 56, "title": "Founder, CEO & Director", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hans  Ageland MSEng", "age": 61, "title": "Founder & COO", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter  Rooslien B.A., BA", "age": 66, "title": "Chief Financial Officer", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ulf  Bjorklund M.Sc.", "age": 66, "title": "Chief Medical Officer", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}